Table 2.
Item b | CON | GOS | P-Value |
---|---|---|---|
Day 8 | |||
GLP-1 (pg/g) | 1.16 ± 0.10 | 1.51 ± 0.10 | 0.033 |
GLP-2 (pg/g) | 2.25 ± 0.23 | 2.66 ± 0.14 | 0.155 |
IGF-1 (ug/g) | 4.38 ± 0.57 | 5.37 ± 0.30 | 0.156 |
EGF (ng/g) | 114.63 ± 10.05 | 153.99 ± 15.50 | 0.059 |
Day 21 | |||
GLP-1 (pg/g) | 1.47 ± 0.13 | 1.69 ± 0.08 | 0.163 |
GLP-2 (pg/g) | 2.83 ± 0.17 | 3.06 ± 0.26 | 0.463 |
IGF-1 (ug/g) | 5.24 ± 0.33 | 6.15 ± 0.60 | 0.216 |
EGF (ng/g) | 154.19 ± 8.90 | 167.18 ± 15.84 | 0.491 |
a Values are means ± SEM, n = 6; CON, a control group; GOS, a galacto-oligosaccharides intervention group. b GLP-1, glucagon-like peptide-1; GLP-2, glucagon-like peptide-2; IGF-1, insulin-like growth factor 1; EGF, epidermal growth factor.